<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02137265</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0343</org_study_id>
    <nct_id>NCT02137265</nct_id>
  </id_info>
  <brief_title>Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Trial of Clomiphene Citrate of Clomiphene Citrate in Hypoandrogenism and Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Prescribed clomiphene citrate to azoospermic patients with hypoandrogenism could&#xD;
      improve the sperm retrieval in either fresh sperm or after surgical sperm extraction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypogonadism (low testosterone level) is frequently observed in men presenting with non&#xD;
      obstructive azoospermia. Controversy exists regarding the efficacy of preoperative hormonal&#xD;
      manipulation in patients with hypogonadism. However, it is possible that hormonal therapy&#xD;
      increases intra-testicular testosterone levels, and with a rise in serum testosterone, sperm&#xD;
      production and surgical success with microTESE improve.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No funding obtained&#xD;
  </why_stopped>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Actual">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of sperm in the ejaculated or in the microsurgical testicular Sperm extraction (microTESE)</measure>
    <time_frame>After four months of clomiphene treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Epigenetic modifications</measure>
    <time_frame>After four months of clomiphene treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Testosterone levels and Bioavailable Testosterone levels</measure>
    <time_frame>After two weeks and four months with clomiphene treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Non Obstructive Azoospermia</condition>
  <condition>Hypogonadism</condition>
  <arm_group>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clomiphene citrate 50 mg daily during 4-6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (1 pill daily) during 4-6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <description>Clomiphene citrate 50 mg orally daily</description>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <other_name>Clomid</other_name>
    <other_name>Serophene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One pill every other day</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years old.&#xD;
&#xD;
          -  Man seeking fertility treatment.&#xD;
&#xD;
          -  Azoospermia confirmed in at least 2 semen analyses with centrifugation.&#xD;
&#xD;
          -  Testosterone &lt;300 ng/dL and Bioavailable Testosterone&lt;156 ng/dL.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of genetic disorders: Y chromosome deletions or abnormal karyotypes.&#xD;
&#xD;
          -  Luteinizing hormone (LH) &gt;25 IU/mL.&#xD;
&#xD;
          -  Estradiol &gt; 40 ng/dL.&#xD;
&#xD;
          -  Hypogonadotropic hypogonadism (LH &lt;2 IU/mL and Follicle Stimulating Hormone (FSH) &lt;1&#xD;
             IU/mL).&#xD;
&#xD;
          -  Obstructive azoospermia (FSH &lt;7.6 IU/mL plus testicle longitudinally axis &gt;4.6 cm or&#xD;
             bilateral absence of vas deferens or surgical history of vasectomy).&#xD;
&#xD;
          -  Clinical varicocele (palpable or visible in physical exam)&#xD;
&#xD;
          -  Previous history of cryptorchidism.&#xD;
&#xD;
          -  Use of chemotherapy, testosterone, or anti-androgen in the last two years. Partner &gt;40&#xD;
             years or female factor infertility associated.&#xD;
&#xD;
          -  Contraindications to clomiphene use: depression, heart and liver impairment,&#xD;
             uncontrolled thyroid/adrenal dysfunction, organic intracranial lesions.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saturnino Luj√°n, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Valencia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Valencia</name>
      <address>
        <city>Valencia</city>
        <state>Province Of Valencia</state>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl. 2005 Nov-Dec;26(6):787-91; discussion 792-3.</citation>
    <PMID>16291975</PMID>
  </results_reference>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Rao P, Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7.</citation>
    <PMID>22958644</PMID>
  </results_reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 9, 2014</study_first_submitted>
  <study_first_submitted_qc>May 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2014</study_first_posted>
  <last_update_submitted>October 1, 2020</last_update_submitted>
  <last_update_submitted_qc>October 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Dr. Craig Niederberger</investigator_full_name>
    <investigator_title>Clarence C. Saelhof Professor and Head, Department of Urology, UIC College of Medicine</investigator_title>
  </responsible_party>
  <keyword>Azoospermia</keyword>
  <keyword>Hypogonadism</keyword>
  <keyword>Clomiphene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azoospermia</mesh_term>
    <mesh_term>Hypogonadism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

